Balloon Dilation of the Eustachian Tube
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Policy governing medical necessity, prior authorization, and coding for balloon dilation of the eustachian tube for treatment of chronic obstructive eustachian tube dysfunction for Medicare Advantage and Commercial products.
No material clinical or coverage changes in this revision.
Coverage Criteria for Balloon Dilation of the Eustachian Tube (BDET)
Initial Therapy / Medical Necessity
Covered when ALL of the following are met
Individuals with patulous eustachian tube dysfunction are excluded from BDET coverage. A diagnosis of patulous ETD is suggested by autophony of voice, audible respirations, pulsatile tinnitus, and/or aural fullness. Also excluded are individuals with extrinsic reversible or irreversible causes of eustachian tube dysfunction, including but not limited to craniofacial syndromes (e.g., cleft palate spectrum), neoplasms causing extrinsic obstruction, history of nasopharyngeal radiation, enlarged adenoids, nasopharyngeal mass, neuromuscular disorders causing hypotonia, and active systemic mucosal or autoimmune inflammatory disease affecting the nasopharynx/eustachian tube.
If services are determined to be not medically necessary or are considered non‑covered benefits under the member's subscriber or employer agreement, they are excluded from coverage. Providers must verify member eligibility and benefits; when a service is not covered or is deemed not medically necessary, the provider may not bill the member unless the member has been informed and has provided written agreement to accept financial responsibility in advance.
Balloon dilation of the eustachian tube is not medically necessary when the policy criteria are not met. Examples include lack of demonstrated reversibility of ETD (no temporary normalization of tympanogram or no visualization of tympanic membrane movement with Valsalva), symptoms that are episodic or occur only with barochallenge, presence of any listed contraindication (including patulous ETD or extrinsic causes), or a history of a prior BDET procedure.
Services determined to be not medically necessary or that are non‑covered benefits under this policy are not covered. Such determinations may lead to claim denial and potential member financial responsibility unless prior written agreement is obtained from the member.
Coding and Procedure Codes
Provider Actions, Authorization, and Documentation Requirements
Obtain prior authorization for BDET (CPT 69705/69706)
Prior authorization is required for Medicare Advantage Plans and recommended for Commercial Products for BDET procedures using CPT 69705 or 69706 when medical criteria are met.
- Obtain prior authorization for Medicare Advantage members before scheduling BDET.
- For Commercial products, follow recommended prior authorization processes as applicable.
Follow related prior-authorization policy and payer requirements
Follow the payer's related prior-authorization policy for services, treatments, or procedures where applicable; contact the payer or refer to the 'Prior Authorization of Services, Treatments or Procedures' policy for specifics.
- Comply with any additional prior authorization processes or documentation required by the payer.
Confirm failure of appropriate medical management before BDET
Document and confirm that the patient has failed appropriate medical management of co-occurring conditions prior to BDET, including trials such as 4–6 weeks of a nasal steroid spray when indicated.
- Ensure medical management for allergic rhinitis, rhinosinusitis, laryngopharyngeal reflux, or other identified conditions was attempted and documented.
Complete diagnostic assessment and prior-treatment documentation
Ensure complete diagnostic workup and prior-treatment documentation are in the record before requesting authorization or performing BDET.
- Record patient-reported questionnaires, history and physical exam findings, and results of tympanometry (if tympanic membrane intact).
- Include nasal endoscopy and comprehensive audiometry findings.
- Document prior medical management efforts and their outcomes (e.g., response to nasal steroid trial).
Required documentation to support medical necessity
Maintain and submit required diagnostic findings to support medical necessity, including abnormal tympanogram or abnormal tympanic membrane, evidence of reversibility, and documentation of prior treatments.
- Include tympanometry results showing Type B or C tympanogram when applicable.
- Document abnormal tympanic membrane findings (retraction, effusion, perforation, etc.).
- Provide evidence of reversibility (e.g., Valsalva producing temporary normalization) and complete history/physical and questionnaires.
Verify member eligibility and benefits with provider call center
Verify member eligibility, benefits, and any plan-specific limitations with the provider call center before obtaining authorization or scheduling procedures.
- Confirm subscriber agreement and employer plan limitations, as these supersede the medical policy.
Denial risk for lack of authorization or unmet criteria
Failure to obtain required prior authorization for Medicare Advantage members or failure to meet the policy's medical criteria (age, symptom duration, diagnostic findings, prior medical management, absence of contraindications, demonstration of reversibility, continuous symptoms, and no prior BDET) may result in claim denial.
- Denials may occur if documentation does not demonstrate all coverage criteria are met.
- Ensure no contraindications (e.g., patulous ETD or extrinsic causes) are present and documented.
Member financial responsibility and billing risk for non-covered services
If services are determined not medically necessary or are non-covered benefits, the service may be denied and providers may not charge the member unless the member was informed and agreed in writing in advance.
- Refer to subscriber and participation agreements for applicable billing provisions.
- Confirm authorization status and medical necessity prior to billing the member.
Background and Clinical Context
The eustachian tube ventilates the middle ear, equalizes middle ear pressure, and protects the middle ear from nasopharyngeal secretions. Dysfunction may result from inflammation or anatomic factors and can present with aural fullness, aural pressure, otalgia, and/or hearing loss. BDET is a transnasal endoscopic procedure that dilates the cartilaginous portion of the eustachian tube with a balloon to improve patency and may be used when comprehensive diagnostic assessment (including tympanometry, nasal endoscopy, and audiometry) demonstrates obstructive ETD and when other causes and contraindications have been addressed.
Definitions and Key Terms
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.